Solvias AG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Römerpark 2, Kaiseraugst, Aargau 4303, Switzerland (CHE)
- Operations here
- analysis
- FDA identifiers
- FEI 3008735083 · DUNS 480739627
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2023-09-01
- NAIDrug Quality Assurance2023-06-09
- VAIDrug Quality Assurance2022-11-22
- NAIDrug Quality Assurance2017-10-27
- VAIDrug Quality Assurance2014-03-07
- VAIDrug Quality Assurance2014-03-04
- NAIDrug Quality Assurance2011-04-08
- VAIDrug Quality Assurance2010-06-24
- NAIDrug Quality Assurance2008-11-04
Drugs this plant is listed as making
4 distinct drugs across 9 products name this site in their FDA label.
- brigatinibTakeda Pharmaceuticals America, Inc.
- deferoxamine mesylateMitem Pharma
- MaribavirTakeda Pharmaceuticals America, Inc.
- PlazomicinCipla Therapeutics Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.